OpenVSafe by OpenVAERS
Search V-safe

D9F-31398-18371

2 vaccinations 5 coded responses 25 check-ins 5 free-text entries 2 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
925 / CA
Registered
2021-03-19
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-19
    Registered in v-safe
  2. 2021-03-19
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-19
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-03-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  5. 2021-03-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  6. 2021-03-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activities
    Adult check-in
  7. 2021-03-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea
    Adult check-in
  8. 2021-03-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  9. 2021-03-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  10. 2021-03-26
    Health check-in — day 7, dose 1
    Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  11. 2021-04-02
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-04-09
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-04-16
    Dose 2 — Pfizer-BioNTech
  14. 2021-04-16
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-04-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Muscle or body aches
    Adult check-in
  16. 2021-04-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  17. 2021-04-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  18. 2021-04-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  19. 2021-04-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  20. 2021-04-23
    Health check-in — day 7, dose 2
    Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  21. 2021-04-30
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-07
    Survey response — day 21, dose 2
    MedDRA: Arthralgia, Chronic inflammatory response syndrome, Erythema, Feeling hot, Joint swelling, Joint warmth, Pre-existing disease, Psoriasis — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Hot, swollen, red, painful joints--began 5/5/21. Could be due to one or more of my chronic inflammatory/autoimmune health conditions. Increased number, size, and severity of psoriasis plaques--began 5/5/21; no known precipitating factors.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-05-14
    Survey response — day 28, dose 2
    MedDRA: Nausea, Pyrexia — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities
    Free text: Severe nausea; intermittent, low-grade fever
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-05-21
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-05-28
    Survey response — day 42, dose 2
    MedDRA: Nausea, Pre-existing disease — Feeling: Good · Be unable to work, Be unable to do your normal daily activities
    Free text: Nausea, which could easily be explained by my other medical conditions
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  26. 2021-07-16
    Survey response — 3 months, dose 2
    MedDRA: Arthritis, Candida infection, Nausea, Overgrowth fungal — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Thrush and systemic yeast overgrowth. Increased nausea. Worsening inflammation in joints.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  27. 2021-07-16
    Report sent to call center — 3 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  28. 2021-07-25
  29. 2021-10-17
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  30. 2022-04-16
    Survey response — 12 months, dose 2
    MedDRA: Migraine — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Migraines
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-04-16
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  32. 2022-04-19

Vaccinations

DoseDateManufacturerCo-administered
12021-03-19Pfizer-BioNTech
22021-04-16Pfizer-BioNTech

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 8 — day 21, dose 2

2021-05-07

Symptoms: Hot, swollen, red, painful joints--began 5/5/21. Could be due to one or more of my chronic inflammatory/autoimmune health conditions. Increased number, size, and severity of psoriasis plaques--began 5/5/21; no known precipitating factors.

Release 8 — day 28, dose 2

2021-05-14

Symptoms: Severe nausea; intermittent, low-grade fever

Release 8 — day 42, dose 2

2021-05-28

Symptoms: Nausea, which could easily be explained by my other medical conditions

Release 9 — 3 months, dose 2

2021-07-16

Symptoms: Thrush and systemic yeast overgrowth. Increased nausea. Worsening inflammation in joints.

Release 11 — 12 months, dose 2

2022-04-16

Symptoms: Migraines

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArthralgia ✓ ✓ ✓
SDArthritis ✓ · ✓
SDCandida infection ✓ · ✓
SDChronic inflammatory response syndrome ○ ✓ ○
SDErythema ✓ ✓ ✓
SDFeeling hot ○ ✓ ○
SDJoint swelling ✓ ✓ ✓
SDJoint warmth ✓ · ✓
SDMigraine · · ✓
SDNausea ✓ ✓ ✓
SDOvergrowth fungal ✓ · ✓
SDPre-existing disease ✓ ✓ ✓
SDPsoriasis ✓ · ✓
SDPyrexia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release